| Stereochemistry | RACEMIC |
| Molecular Formula | C19H28N2O4 |
| Molecular Weight | 348.4366 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OC(=O)C1=CC2=C(N1)C=CC=C2OCC(O)CNC(C)(C)C
InChI
InChIKey=SJYFDORQYYEJLB-UHFFFAOYSA-N
InChI=1S/C19H28N2O4/c1-12(2)25-18(23)16-9-14-15(21-16)7-6-8-17(14)24-11-13(22)10-20-19(3,4)5/h6-9,12-13,20-22H,10-11H2,1-5H3
| Molecular Formula | C19H28N2O4 |
| Molecular Weight | 348.4366 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
Patents
Sample Use Guides
anticonflict effect of m-CPP in rats: The anticonflict effect of m-CPP (0.25 mg/kg) was antagonized by the beta-adrenoceptor blocker SDZ 21009 (2 and 4 mg/kg) with affinity for 5-HT1A and 5-HT1B receptors
Route of Administration:
Oral
The inhibitory effects of serotonin (5-HT), α-methylserotonin (α-met-5-HT) and 5-carboxamidotryptamine (5-CT) were attenuated by the non-specific 5-HT antagonist methiothepin (1 μM) and by the 5-HT1A/1B antagonist SDZ 21009 (100 nM) but not by the selective 5-HT1A antagonist WAY 100135 (1 μM).
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
Showing 1 to 2 of 2 entries
